Biomagnetics to Hold Rescheduled Investor Conference Call to Introduce World Class Biosensor Technology for Malaria, HIV and Tuberculosis Diagnosis
SAN FRANCISCO–(BUSINESS WIRE)– Biomagnetics Diagnostics Corp., (Pink Sheets:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection will hold an investor conference call to discuss upcoming business opportunities and its agreement with Los Alamos National Security, one of the world’s premiere research laboratories.
Specifically, the rescheduled call, which will be open to all investors, will be held on Thursday, December 3rd at 4:30 EST. Interested parties may dial into the Biomagnetics Diagnostics Corp. conference call using the toll free dial-in number (US & Canada) of (877) 274-7449 or the local/international dial-in number of (763) 488-8345. The conference ID number to access the call is 45166038. (The call, previously scheduled for today, Wednesday December 2nd, was rescheduled for tomorrow, Thursday December 3rd, when an apparent attempt by National Public Radio (NPR) to cover and record the Biomagnetics Diagnostics Corp. conference call caused technical difficulties.)
The Company recently announced on November 30th that it has finalized a “Patent License Agreement with Los Alamos National Security.” Under the agreement, Biomagnetics will have access to the Triggered Optical Biosensor and Integrated Optical Biosensor System (IBOS) technology developed at Los Alamos National Laboratory.
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s revolutionary diagnostic systems, which are based on advanced magnetic and optics, test for any viral or bacterial disease using any body fluid. The Company’s technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. More information on Biomagnetics Diagnostics Corp. can be seen at www.BiomagneticsBMGP.com.